Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: how firm is the Aspergillus diagnosis?

The Journal of Infection
Sarah P Georgiadou, Dimitrios P Kontoyiannis

Abstract

Immunocompromised patients with hematological malignancies and/or recipients of hematopoietic stem cell transplants are constantly exposed to several fungal, bacterial, and viral respiratory pathogens. We retrospectively evaluated all patients with invasive pulmonary aspergillosis (IPA) and underlying hematological malignancies for the presence of concurrent, microbiologically documented pulmonary infections during a 5-year period (2005-2010). We found 126 such patients that frequently had coinfections (49%) with respiratory pathogens other than Aspergillus species, with a higher rate in patients with probable IPA (53%) than in those with proven IPA (29%; P=0.038). As the majority of patients with IPA in daily practice have probable IPA, often according to only the combination of positivity for serological biomarkers and radiological findings, our data may raise skepticism about both the certainty of IPA diagnosis and the evaluation of response to antifungals in a subset of these patients.

References

Sep 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M JandrlićV Bogdanić
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AbbasiP M Flynn
Jun 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D P KontoyiannisK V Rolston
Jan 25, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David W DenningHartmut Lode
Aug 9, 2002·The New England Journal of Medicine·Raoul HerbrechtUNKNOWN Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillu
Aug 31, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George J AlangadenUNKNOWN Bone Marrow Transplant Group
Sep 28, 2002·Medicine·Harrys A TorresDimitrios P Kontoyiannis
Jun 16, 2004·Nature Reviews. Microbiology·Lauren O Bakaletz
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johan MaertensUNKNOWN Caspofungin Salvage Aspergillosis Study Group
Jun 7, 2005·Diagnostic Microbiology and Infectious Disease·Alfred Lennart BissingerHolger Hebart
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshJohn R Perfect
Apr 20, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Oliver A CornelyUNKNOWN AmBiLoad Trial Study Group
Jun 21, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kenneth V I RolstonAmar Safdar
Jul 31, 2007·Diagnostic Microbiology and Infectious Disease·Jessica R CummingsRandall T Hayden
Jun 4, 2008·Medicine·Kalen L JacobsonDimitrios P Kontoyiannis
Jun 11, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Monique A S H Mennink-KerstenPaul E Verweij
Jul 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Georgios ChamilosDimitrios P Kontoyiannis
Jul 30, 2008·Infection and Immunity·Maureen H DiazAlan R Hauser
Oct 7, 2008·The Journal of Antimicrobial Chemotherapy·R Y HachemI I Raad
Mar 10, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ronen Ben-AmiDimitrios P Kontoyiannis
Dec 17, 2009·European Journal of Haematology·Pranatharthi Chandrasekar
Feb 9, 2010·The Journal of Infection·Marcela CampoDimitrios P Kontoyiannis
Mar 3, 2010·Scandinavian Journal of Infectious Diseases·Viboon BoonsarngsukKanchana Sriwanichrak
Mar 30, 2010·Nature Reviews. Microbiology·Anton Y PelegEleftherios Mylonakis
Apr 9, 2010·Science Translational Medicine·Aimee K ZaasGeoffrey S Ginsburg
Jan 5, 2011·The Journal of Antimicrobial Chemotherapy·Manuel Cuenca-EstrellaThomas R Rogers
Apr 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sarah P GeorgiadouDimitrios P Kontoyiannis
Apr 20, 2011·The Journal of Infectious Diseases·Dimitrios P Kontoyiannis
Aug 19, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Simone A NouérElias Anaissie
Aug 26, 2011·Intensive Care Medicine·Gaston BurghiElie Azoulay
Dec 17, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marta StanzaniNicola Vianelli
Dec 22, 2011·JAMA : the Journal of the American Medical Association·Jonathan S BoomerRichard S Hotchkiss
Dec 29, 2011·JAMA : the Journal of the American Medical Association·Alejandro R JadadJennifer Jones
Dec 30, 2011·Journal of Clinical Microbiology·Anna Maria TortoranoGiuliana Lo Cascio
Jan 11, 2012·Clinical Microbiology Reviews·Brian M PetersMark E Shirtliff

❮ Previous
Next ❯

Citations

Dec 7, 2013·Best Practice & Research. Clinical Haematology·Dimitrios P Kontoyiannis
May 7, 2013·Asian Pacific Journal of Tropical Biomedicine·Stephen ChegeVincent Obanda
Nov 29, 2014·BMC Infectious Diseases·Lara Zafrani, Elie Azoulay
May 17, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G MaschmeyerUNKNOWN Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology
Jul 19, 2015·The Journal of Antimicrobial Chemotherapy·S DavoudiD P Kontoyiannis
Jan 30, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Russell E LewisPierluigi Viale
Jul 2, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas F PattersonJohn E Bennett
Jul 27, 2018·Journal of Thoracic Imaging·Cristina Vazquez GuillametRodrigo Vazquez Guillamet
Jul 2, 2014·Clinical Microbiology Reviews·Marios ArvanitisEleftherios Mylonakis
Jul 2, 2016·Medicine·Alexander M TataraDimitrios P Kontoyiannis
Jul 6, 2017·International Journal of Environmental Research and Public Health·Mary Augustina EgbutaOlubukola Oluranti Babalola
Mar 15, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ana Fernández-CruzDimitrios P Kontoyiannis
Aug 28, 2020·Blood·Pedro Puerta-AlcaldeDimitrios P Kontoyiannis
Mar 5, 2021·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·François DanionUNKNOWN Collaborators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.